APA (7th ed.) Citation

Murakami, Y., Kusakabe, D., Watari, K., Kawahara, A., Azuma, K., Akiba, J., . . . Ono, M. (2022). AXL/CDCP1/SRC axis confers acquired resistance to osimertinib in lung cancer. Nature Portfolio.

Chicago Style (17th ed.) Citation

Murakami, Yuichi, Daiki Kusakabe, Kosuke Watari, Akihiko Kawahara, Koichi Azuma, Jun Akiba, Masahiko Taniguchi, Michihiko Kuwano, and Mayumi Ono. AXL/CDCP1/SRC Axis Confers Acquired Resistance to Osimertinib in Lung Cancer. Nature Portfolio, 2022.

MLA (9th ed.) Citation

Murakami, Yuichi, et al. AXL/CDCP1/SRC Axis Confers Acquired Resistance to Osimertinib in Lung Cancer. Nature Portfolio, 2022.